BIWEEKLY CARBOPLATIN AND PACLITAXEL AS FIRST-LINE THERAPY FOR ELDERLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS (PHASE II STUDY)

被引：0
|
作者：
Kota, I. [1 ]
Soejima, K. [1 ]
Naoki, K. [1 ]
Yasuda, H. [1 ]
Terai, H. [1 ]
Daisuke, A. [1 ]
Ohgino, K. [1 ]
Yoda, S. [1 ]
Ikemura, S. [1 ]
Betsuyaku, T. [1 ]
机构：
[1] Keio Univ, Sch Med, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：422 / 422
页数：1
相关论文
共 50 条
  • [31] RANDOMISED PHASE II STUDY OF AXITINIB OR BEVACIZUMAB COMBINED WITH PACLITAXEL/CARBOPLATIN (PAC/CARB) AS FIRST-LINE THERAPY FOR PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Twelves, C.
    Chmielowska, E.
    Havel, L.
    Popat, S.
    Swieboda-Sadlej, A.
    Sawrycki, P.
    Bycott, P.
    Niethammer, A.
    De Besi, P.
    Schiller, J. H.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 409 - 409
  • [32] Phase II trial of docetaxel and gefitinib as first-line therapy for elderly patients with advanced non-small cell lung cancer (ANSCLC).
    Williams, CC
    Haura, EB
    Antonia, SJ
    Chiappori, A
    Bepler, G
    Simon, GR
    Moffitt, HL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 701S - 701S
  • [33] Phase II Study of Docetaxel and Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer
    Yoshimura, Naruo
    Kudoh, Shinzoh
    Kimura, Tatsuo
    Mitsuoka, Shigeki
    Kyoh, Shigenoir
    Tochino, Yoshihiro
    Asai, Kazuhisa
    Kodama, Toyoki
    Ichimaru, Yukikazu
    Yana, Takashi
    Hirata, Kazuto
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (03) : 371 - 375
  • [34] A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer
    Mori, Kiyoshi
    Kamiyama, Yukari
    Kasai, Hisashi
    Kodama, Tetsuro
    [J]. CHEMOTHERAPY, 2012, 58 (01): : 78 - 83
  • [35] A Phase II First-Line Study of Gemcitabine, Carboplatin, and Bevacizumab in Advanced Stage Nonsquamous Non-small Cell Lung Cancer
    Clement-Duchene, Christelle
    Krupitskaya, Yelena
    Ganjoo, Kristen
    Lavori, Philip
    McMillan, Alex
    Kumar, Atul
    Zhao, Gary
    Padda, Sukhmani
    Zhou, Lisa
    San Pedro-Salcedo, Melanie
    Colevas, A. Dimitrios
    Wakelee, Heather A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (11) : 1821 - 1825
  • [36] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
    Usui, K
    Inoue, A
    Ishimoto, O
    Tanaka, M
    Koinumaru, S
    Matsubara, N
    Kanbe, M
    Gomi, K
    Saijo, Y
    Nukiwa, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
  • [37] Cisplatin and weekly docetaxel as first-line therapy in patients with advanced non-small cell lung cancer a phase II study
    Tartarone, A
    Romano, G
    Iodice, G
    Capobianco, A
    Coccaro, M
    Bochicchio, A
    Di Leo, P
    Ardito, R
    Di Renzo, N
    [J]. TUMORI, 2005, 91 (02) : 131 - 134
  • [38] Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial
    Gervais, Radj
    Robinet, Gilles
    Clement-Duchene, Christelle
    Denis, Fabrice
    El Kouri, Claude
    Martin, Philippe
    Chouaki, Nadia
    Bourayou, Nawel
    Morere, Jean-Francois
    [J]. LUNG CANCER, 2013, 80 (02) : 185 - 190
  • [39] First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Results of the NEPTUN study
    Dechow, Tobias
    Riera-Knorrenschild, Jorge
    Hackanson, Bjoern
    Janssen, Jan
    Schulz, Holger
    Chiabudini, Marco
    Fischer von Weikersthal, Ludwig
    Budweiser, Stephan
    Nacke, Axel
    Taeuscher, Dagmar
    Welslau, Manfred
    Potthoff, Karin
    [J]. CANCER MEDICINE, 2021, 10 (22): : 8127 - 8137
  • [40] Phase II study of meloxicam with carboplatin plus docetaxel in first-line treatment of patients with advanced non-small cell lung cancer (NSCLC)
    Ishida, T.
    Kanazawa, K.
    Oizumi, H.
    Yokouchi, H.
    Yamazaki, K.
    Akie, K.
    Sukoh, N.
    Harada, M.
    Munakata, M.
    Isobe, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345